Drug-induced hERG Block and Long QT Syndrome

Period Correction of the QTc of Moxifloxacin With Multiple Predose Baseline ECGs Is the Least Variable of 4 Methods Tested

(2009) Xiaoping Zhang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Time to Replace Bazett's QT-Correction

(2009) RAYMOND L. WOOSLEY et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Pharmacology of the short QT syndrome N588K-hERG K+channel mutation: differential impact on selected class I and class III antiarrhythmic drugs

(2008) M J McPate et al.   BRITISH JOURNAL OF PHARMACOLOGY

hERG Potassium Channels and the Structural Basis of Drug-Induced Arrhythmias

(2008) John S. Mitcheson   CHEMICAL RESEARCH IN TOXICOLOGY

Drug Binding to the Inactivated State Is Necessary but Not Sufficient for High-Affinity Binding to Human Ether-a-go-go-Related Gene Channels

(2008) M. J. Perrin et al.   MOLECULAR PHARMACOLOGY

High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology

(2008) John Dunlop et al.   NATURE REVIEWS DRUG DISCOVERY

State dependent dissociation of HERG channel inhibitors

(2007) D Stork et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Composite Model for hERG Blockade

(2007) Christian Kramer et al.   ChemMedChem